CKD-HPT, HP and HK market to reach $4bn across 7MM by 2034
With $1.5 billion in drug sales, the US dominated the CKD-HPT, HP and HK market in 2024, representing 59.7% of 7MM sales.
Clinical Trials Arena
Rise of ultra-processed food is detriment to global health
Measles-free status of Canada revoked
Obstructive sleep apnea independently associated with cerebral microbleeds
IDWeek 2025: EL219 shows favourable safety and PK profile in Phase I studies
Driving digital solutions through rapid experimentation
